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ONE HUNDRED AND EIGHTY PATIENTS
with positive cervical smears, but no
clinical evidence ofinvasive cancer, elected
to be sensitizedto DNCB andsubsequently
have DNCB applied to the cervix. Twenty-
five patients did not become sensitized to
DNCB. Of the remaining 155 patients,
the smear test remained positive in 105,
but became negative in 50. Fourteen ofthe
50 patients were subsequently operated
on and no histological evidence of malig-
nancy was found. The remaining 36
patients were followed up and 4 of these
have developed recurrent positive smears.
The average duration of follow-up is
38 months (range 5-80 months). As this
treatment is successful in only 32% of
patients, it is not recommended in the
routine management of patients with
positive cervical smears.
The use of the delayed hypersensitivity
response as a form of immunotherapy for
patients with skin cancer has been known
for some years (Klein, 1968). The success-
ful application ofthis method to the treat-
ment of non-clinical carcinoma of the
vagina has already been described by us
(Guthrie & Way, 1975). Patients with
non-clinical carcinoma of the cervix are
much more frequent and we have been
investigating the use of this method of
treatment in these patients. The basic
principle is to sensitize the patient to
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dinitrochlorobenzoate (DNCB) and then
apply an appropriate concentration of
DNCB to the cervix. Immunocytes will
then migrate to the cervix in large num-
bers, where it is hoped they will destroy
the relatively small number of malignant
cells which are present.
Patients.-All patients had at least 2
cervical smears showing malignant cells.
Afullpelvic examination was done on each
patient to exclude gross evidence of
disease. Any patient with cervical appear-
ances suggesting invasive malignancy was
excluded from the trial. No biopsies of
the cervix were done before treatment. All
patients were made fully aware of the
nature of their condition and the nature
of the proposed treatment, and their full
consent obtained.
Method.-Patients were instructed to
apply a small amount of 0-1% concentra-
tion of DNCB in an aqueous base cream
inside a 1 cm diameter circle drawn on
any part of the skin. The cream was to be
re-applied at least once a day, the object
being always to have some DNCB cream
in contact with the skin at that point.
No dressing was applied. Thepatients were
instructed to stop applying the cream at
the first sign of local reaction and to
telephone the hospital, when arrangements
were made for them to be seen as out-
patients for patch testing to assess the
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degree of sensitivity. Four concentrations
ofDNCB in an aqueous base cream (0100%,
0.05%, 0.005% and 0.0005%) were applied
to individual marked areas on the skin
and a simple dressing applied.
Forty-eight hours later, anote was made
of the degree of sensitivity by assessing
the degree oferythema, induration and the
presence or absence of vesicles or, occa-
sionally, bullae. Each patient was scored
on a scale ranging from 0 to 5, those with
only erythematous reactions scoring 1,
whereas those with reactions to all 4
concentrations of DNCB, with induration,
scored 5. That concentration of DNCB
which just producedinduration was chosen
for treatment, or, if no induration was
found, a 0 1% concentration was used.
Other tests ofthe patient's immunological
status were not done.
To facilitate treatment, the patient was
placed in the lithotomy position, the cervix
visualized and then, with the exception
of the first 24 patients, the cervix was
swabbed with an aqueous solution of
sodium bicarbonate in an attempt to
remove cervical mucus. Fourteen ml of
the appropriate concentration of cream
was then applied to the cervix, using a
20 ml syringe with a 12 cm rigid plastic
tube attached tothenozzle. Carewas taken
to ensure that some of the cream was
inserted in the endocervical canal. A
plastic foam tampon, about 5 x 5 x 7 cm,
was then placed in the vagina. The cervical
aspect of this tampon had previously
been impregnated with the appropriate
concentration ofDNCB, whereas that part
near the introitus remained dry, so as to
absorb any potential leakage of DNCB
from the rest ofthe vagina. Non-permeable
strings were attached to the lower end of
the sponge, enabling the patient to remove
it at home 48 h later. Patients were advised
not to sit in the bath or go swimming for
1 week after treatment and not to have
sexual intercourse for 4 weeks. Treatment
was always timed to be immediately after
a menstrual period, so that there was no
chance of subsequent menstrual flow
washing the DNCB offthe cervix. Patients
were also warned not to have treatment
with chloramphenicol, in view of the
possibility of cross-sensitization, and their
doctors were advised not to prescribe this
to such patients (Pye & Burton, 1976).
Patients were subsequently seen for repeat
cervical cytology not less than 6 weeks
later. If the cervical cytology was normal,
repeat cervical smears were taken every
3 months for the first 2 years, and every
6 months after that. Ifthe cervical smears
remained positive, arrangements were
made for surgical treatment. Fourteen
patients whose smears were negative after
treatment volunteered for surgery, thus
enabling histological confirmation of the
absence of malignancy.
Results. Other than the mild dis-
comfort ofthe initial reactions on the skin,
no patient suffered any side effect as a
result of this treatment.
Of 180 patients admitted to the trial,
25 (14%) did not become sensitized to
DNCB and did not therefore have DNCB
applied to the cervix. All of them were
subsequently treated surgically, with the
exception of 2 patients who left the area
and who could not be traced in spite of
every effort. The remaining 155 patients
became sensitized after an average of 27
days. One hundred and five of these
patients (68%) had smears which remained
positive aftertreatment; 50patients (32%)
had normal smears after treatment. The
patients whose smears became normal
after treatment took, on average, less
time to become sensitized to the DNCB
and their degree of sensitivity was, on
average, greater than that of patients in
whom the smears remained positive.
Twenty-three per cent of the patients in
the treatment-failure group had a Grade
1 reaction, as opposed to 12% in the treat-
ment-success group, and 3% of the treat-
ment-failure group had a Grade 5 reaction
as opposed to 4% in the treatment-
success group. There is, however, no
statistically significant difference between
groups when comparing the degree of
sensitivity of all patients.
Ofthe 50 patients whose smears became
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negative, 14 had surgery short]
wards, and histology of the cerv
of these revealed no abnormalit
but in 4 ofthem there was some 1
hyperplasia. The remaining 36
were followed up and 4 of them di
recurrent positive smears at 15, 1
27 months respectively. Histolo}
of these patients showed a smal
intra-epithelial carcinoma with
vasion. The remaining patients h
followed up for an average of 3
5-80) months. Of these patients
present pregnant and 8 have
pregnant since treatment, all pre
having resulted in live healthy bal
no problems relating to the c
vagina. Two of these patients
viously been investigated for ir
without any apparent cause bein
The distribution of the histolo~
treatment failures is shown in t
TABLE.-Histology of DNCB
failures compared with those ti
surgery alone
Surgical
treatment
Cervical histology only
Total patients 1684
Occult carcinoma 30%
Micro-invasive
carcinoma 110%
Intra-epithelial carcinoma
with gland invasion 45%
Intra-epithelial
carcinoma 410%
and, for comparative purposes, t]
bution of the histology of a serie:
patients treated by surgery alon
of us (S.W.). Marked lymphocyti
tion of the cervix was frequent
in the histology of the DNCB ti
failures, and often there would be
of destruction of epithelium
vaginal aspect of the cervix,
malignant change atthe squamo-c
junction in the endocervical c
mained apparently unchanged.
Swabbing the cervix with sodiu
bonate solution made no diffei
the results of treatment.
ly after- Discussion. The histology ofthe treat-
rix in 10 ment failures early in this series suggested
)y at all, to us that the cervical mucus might be
basal-cell forming a kind of barrier to the DNCB.
patients However, attempts to remove the mucus
eveloped in subsequent patients with the use of a
8, 21 and sodium bicarbonate solution produced no
gy of all change in the results. In practice, we now
1 area of believe that it is impossible to remove
Yland in- this mucus completely, and that it is this
ave been mucus which accounts for the marked
8 (range difference in the results of this treatment
, 1 is at when comparing its use in lesions of the
become vagina (Guthrie & Way, 1975) and the
-gnancies cervix.
bies, with The comparison of the distribution of
ervix or the histology between those patients
had pre- treated with surgery alone and those
ifertility, DNCB treatment failures subsequently
ig found. treated surgically would suggest that in
gy of the most of the DNCB failures there has been
he Table some destruction of malignant cells, in
that there are fewer of the more extensive
treatment lesions at the top of the chart when com-
reated by pared with the series treated by surgery
alone. Such partial success is of no value,
DNCB however, in that total destruction of all
fatihere, malignant cells must be achieved before
surgery the patient may be regarded as cured.
105 Histological confirmation ofthepresence
0% ofa malignant lesion before treatment was
4% not obtained, since there has always been
a good correlation between the finding of 36%o a positive smear and the subsequent find-
60% ing of a malignant lesion on histology in
the local laboratory. Furthermore, it is
he distri- known that the removal ofpart of a lesion
s of 1684 may result in the destruction of an adja-
e by one cent area of abnormal tissue or may even
c infiltra- in itself be sufficient to remove an entire
ily noted lesion if small, and hence it could have
reatment been argued that "cure" in such patients
evidence was brought about by surgical rather than
on the immunological means. Hence the deliber-
whereas ate decision was made to restrict the
-olumnar means of diagnosis of cervical pathology
anal re- to cytology and clinical examination alone,
whilst realising that some would regard
[m bicar- this as a serious methodological defici-
rence to ency.
Another criticism of this work is the
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lack of a proper control group. Such a
group should ideally be a number of
patients matched by age with the treat-
ment group and followed up for an equal
length of time, having cytological and
clinical examination as frequently as the
treated patients. Many would argue, how-
ever, that this would be unethical in that
some of those patients may develop a
clinical carcinoma of the cervix during
that time, and that this would obviously
jeopardize their chances of complete cure.
For this reason, the only "control" group
used has been that of a retrospective
series of 1684 patients, all of whom had
undergone cytology and treatment in the
same department as the patients who
received immunotherapy.
It is now generally accepted that about
30% of patients with positive cervical
cytology will never develop a clinically
invasive lesion of the cervix. It is possible
to speculate that this treatment is only
effective in this particular group of
patients but there is, of course, no way of
telling whether indeed it is this 30%0 of
patients or another 30 0 in which the
treatment has been successful.
In view ofthe fact that this treatment is
successful in only 32% of patients, and
that there have been 4 recurrent positive
smears in those who have been followed
up, we believe that this treatment should
not be used in the routine management
of patients with positive cervical smears,
but it does indicate that a search for a
more reliable method of immunotherapy
is worthwhile. The results from the treat-
ment of intra-epithelial cervical cancer
should in no way detract from the success
we have previously achieved in treating
lesions of the vagina in patients who have
previously had a hysterectomy.
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